Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic effect of oral hydroxychloroquine in close contacts of COVID-19 patients
IRCT20200513047426N1Phase 3Completed
- Sponsor
- Bushehr University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Bushehr University of Medical Sciences. Started Jun 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200513047426N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200513047426N1.